Form innovative partnerships: Turn collaboration into sustained strategic advantage

A common myth: “We’re partnering, so we should be moving forward”

Providers are not short on potential partners. Competitors, pharmaceutical and medtech companies, technology firms, payers, and new entrants are often eager collaborators. Across the provider sector, partnership activity is everywhere.

But activity is not the same as progress. Many partnerships are being unwound, rationalized, or reconsidered. Partnerships may include shared-control arrangements, including joint ventures, strategic alliances, and operating partnerships. What looks like momentum is often evidence that earlier bets failed to strengthen an enterprise in lasting ways.

Partnerships are not inherently strategic

Partnerships become strategic when they are designed with intent, with clarity about what they reinforce, what they trade away, and whose advantage they compound. Just as important is how individual partnerships fit together in concert rather than in isolation.

Achieving the right partnership model requires more than strategy and diligence. It demands digital maturity, aligned physician incentives, interoperable data infrastructure, cultural and workforce alignment, and sustained capital investment. Not every provider will be well-positioned to shift in this direction.

Too often, partnerships are reactions to board requirements, market pressures, or competitor moves. Motion mistakenly substitutes for direction. The cost is not just underperforming partnerships with unrealized potential, but squandered time, capital, leadership focus, and future options.

The next era of provider partnerships can reward those who partner with conviction, proactively, and anchor to a long‑term strategic position rather than short‑term momentum.

Reasons to believe

Healthcare is undergoing structural change driven by sustained economic pressure, accelerating technology adoption, medical advances, and shifting consumer expectations. Three reasons explain why partnerships have become a key mechanism for navigating this shift.¹

• Margin pool compression is reshaping the economics of care. Sustained economic pressure is no longer episodic—it’s structural. At PwC, we project medical cost trend will reach 8.5% for large employer plans this year, accelerating shifts in where and how care is delivered. Margin pools are moving away from hospital-based settings toward ambulatory, specialty, and risk-based models. This shift is already visible. Hospital inpatient utilization has been declining while outpatient and ambulatory volumes continue to grow as a share of total care delivery. This will require the right partnerships and infrastructure to capture value in lower-acuity care.
  
  The effectiveness of partnerships is increasingly a defining factor in how margin pools are defended, reallocated, or forfeited. In this environment, collaboration isn’t about scale for its own sake but about deliberately structuring and executing partnerships to enable organizations to reposition in a shifting economic architecture.
• Innovation velocity now exceeds internal build capacity. The pace of innovation in healthcare is accelerating beyond what most providers can build on their own. Advanced therapies, AI-enabled care models, specialty platform economics, and digital front-door capabilities require capital, data infrastructure, and operational sophistication that few systems can develop independently at scale.
  
  Innovation cycles are shortening while capital requirements are increasing. Successful partnerships have shifted from opportunistic to essential to grow and to remain clinically and digitally relevant.
• Partnerships now determine who controls the system. Partnerships are no longer bolt-on undertakings. They shape who controls access, who influences economics, and who orchestrates care delivery. As digital navigation layers, specialty platforms, and risk-based models expand, the structure of partnerships determines whether providers design the ecosystem or operate within someone else’s sphere of control. Control should not be dictated by owning more assets, but by securing the right assets and access points that anchor patient flow, data, and referral influence. Provider strategy can define whether they lead, follow, or become intermediated in the decade ahead.  

Before pursuing a new partnership, ask strategic questions. Inventory your existing partnerships. Which arrangements are compounding advantage? Which are neutral? Which are dilutive? Strategic winners are as disciplined about exiting non-compounding partnerships as they are about forming new ones. Leadership time and capital are finite.

Winning providers apply discipline before designing these partnerships. They consistently ask those three strategic questions regardless of partner type or market pressure. These aren’t theoretical exercises. They are decision filters that determine where leadership attention and strategic capacity are invested.

What does this look like in practice? Winning providers do not partner broadly. Instead, they partner deliberately around a few enterprise priorities. This usually means a small set of repeatable plays like extending specialty access, strengthening the ambulatory and virtual front door, improving navigation and referral capture, accelerating risk-based care, or adding capabilities that are too slow or too costly to build alone. The goal isn’t more partnerships. It’s an ecosystem in which each partnership reinforces the same strategic position.  

The most effective provider partnerships concentrate enterprise advantage. The least effective ones add volume without strengthening performance. What advantage means may vary by system. It may include clinical differentiation, but also access density, referral control, consumer reach, cost position, or risk capabilities. The test is not whether a partnership strengthens a core academic or specialty asset, but whether it reinforces the system’s chosen sources of advantage.

Partnerships done right reallocate activity, capability, or access in ways that strengthen the system’s ability to win. That may include concentrating complex care, expanding access points, improving referral capture, or lowering cost to compete in new sites of care.

Innovator’s move: The next generation of competitor partnerships will move beyond shared programs to shared clinical operating models, where providers jointly orchestrate access, capacity, and care pathways across systems without consolidating ownership or brands. Competitive advantage could increasingly come from how effectively providers coordinate care, not the number of their partnerships. The cost of scale without strategy is real. Chasing volume alone often distracts from deepening clinical differentiation, the one advantage competitors cannot easily replicate. Given heightened antitrust scrutiny, shared operating models should be structured carefully to avoid coordination risks while still enabling clinical and operational integration.  

Many partnerships emerge in response to pressure, whether capital constraints, labor shortages, or technology gaps. Truly strategic partnerships, however, remain attractive even as conditions change. They’re designed for durability, grounded in a value proposition that extends well beyond a near‑term need. Because partnerships demand sustained leadership attention, capital, and operational energy, their value should remain evident over time. When it does not, the balance quickly tips from value creation to resource drain. Durability demands proactive intent, clearly defined metrics, and a quantifiable rationale.

Across pharmaceutical, medtech, and capital partnerships, winners embed value into operating models, not transactions. Pharma partnerships that redesign care models around advanced therapies, rather than simply securing product access, build durable clinical and operational capability. Medtech collaborations that align economics to outcomes accountability can improve total cost of care rather than device utilization. Providers can apply these adjacent-sector lessons to structure partnerships that compound capability, not just activity.

Innovator’s move: Looking ahead, providers will increasingly incubate clinical, digital, and operational platforms that can scale independently before being reintegrated as strategy matures (For example, form a NewCo with outside capital and scale across markets while retaining governance rights and a path to reintegration or ownership expansion later). These models allow providers to access speed and capital without hard-coding long-term constraints. The tradeoff is often underestimated. Solving today’s problems by giving up future strategic flexibility is hard to undo. These models succeed only when leadership, talent, and governance are designed deliberately. Split focus, unclear reintegration rights, and cultural resistance can erode the very optionality they are meant to create.  

Every partnership redistributes influence over economics, data, and care pathways. The question is whether providers are designing the care ecosystem or being intermediated by it. In practical terms, leverage means control of three elements—patient entry and referral flows, the data layer that informs decisions, and the margin pools that fund the enterprise. If a partnership shifts control of any of these externally, leaders should be explicit about that tradeoff.

Partnerships done right with payers, technology firms, and new entrants preserve provider ownership of data, workflows, and patient relationships. Provider-owned technology platforms embedded across the patient journey (think about access, navigation, and care delivery) allow partners to supply infrastructure and speed without controlling the system. Payer-provider partnerships that reduce friction through shared data definitions, aligned care management, and administrative simplification rebalance burden while improving transparency and predictability.

This is where ecosystem strategy becomes tangible. Be clear about which control points you need to own: the digital front door, referral management, the data layer, and risk infrastructure. The top partnerships can add speed, capital, or capability without giving away stewardship of patient relationships, care pathways, or decision-making.

Innovator’s move: The next evolution will be provider-led orchestration layers that sit above individual care settings, coordinating access, navigation, and economics across multiple partners and sites of care. Providers that control orchestration shape utilization, experience, and cost rather than reacting to external rules.  

Today, a patient searches for care online. They end up in an urgent care facility; referrals are inconsistent, payer authorization delays care, specialty capacity is uneven. No one sees the whole journey. In tomorrow's provider-led orchestration model, the health system owns the digital front door. Navigation teams triage and route patients, AI helps direct the appropriate level of care, referrals are centrally managed, capacity is balanced in real time, payer rules are integrated into workflows, and data flows seamlessly across the ecosystem. The provider is not just delivering care; they’re directing the flow of care. The stakes are structural. Partnerships are bets on future influence. Once dependence grows faster than provider stewardship, value diminishes. Reclaiming it is extraordinarily difficult.

Partnership discipline is no longer tangential. It’s a core leadership competency on par with capital allocation and enterprise strategy. In today’s environment, strategy and diligence alone are insufficient. Partnerships demand clear intent, strong governance, and post‑close accountability to avoid becoming costly distractions or regretted uses of resources. Partnerships are no substitute for strategy, they are expressions of it. In the next era, advantage will belong to providers who design ecosystems deliberately and act with conviction, compounding influence over time rather than reacting to momentum or pressure.

A practical roadmap is straightforward. Define where your enterprise should win, identify the capabilities required, and then partner only when doing so strengthens your position without weakening control. That shifts the question from “Who should we partner with?” to “Which plays will reinforce our strategy?” In the coming decade, providers will either orchestrate the ecosystem or operate as high performing nodes within someone else’s system. Partnership strategy will determine which future they inhabit.